Tag Archives: Warren Woessner

Time For Myriad To Fight Another Day

Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , , , | 2 Comments

ACLU Files Petitioners’ Brief in AMP v. Myriad Appeal

On January 13th, AMP et al. filed a 59 page brief contended that human DNA, including DNA fragments, RNA and cDNA, should not be considered patent-eligible under 35 USC s. 101. There is a lot to read here, much of … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , | 1 Comment

USPTO Publishes Final Rules for Micro-Entity Status and Fee Schedule

On December 19, 2012, the Patent Office published the final rule: “Changes to Implement Micro Entity Status for Paying Patents Fees” –77 Fed. Reg. 75019–and on January 18, 2013 the final fee schedule is expected to be published (link below). … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , , , , , | 1 Comment

PTO Issues Notice on Improvement in Patent Application Quality – A Very Modest Proposal

On January 15, 2013, the USPTO released a notice – see link below – requesting comments on its suggestions of ways to “improve the quality of issued patents” by improving the quality of application drafting. There are two brief sections … Continue reading

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment